skip to content

Broker Views

Broker Forecast - Goldman Sachs issues a broker note on AstraZeneca PLC

30 August 2017 13:10

Goldman Sachs today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 3800p (from 3900p).

Story provided by StockMarketWire.com

Related Company: AZN

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

-

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.